F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 107,286 shares at $25.73 ($2.8M) on 2023-01-25, disclosed to the SEC on 2023-01-26.
Open-market sale of $2.8M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.03 | 25,921 | $675K | 24.5% |
| 2 | $26.03 | 25,921 | $675K | 24.5% |
| 3 | $25.28 | 20,467 | $517K | 18.8% |
| 4 | $25.28 | 20,467 | $517K | 18.8% |
| 5 | $25.73 | 7,255 | $187K | 6.8% |
| 6 | $25.73 | 7,255 |
| $187K |
| 6.8% |
| Total | $25.70 avg | 107,286 | $2.8M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |